Cincinnati Eye Institute, an EyeCare Partners Practice, Opens New CEI Retina Clinic at The Landings in Blue Ash
2023-12-08
CINCINNATI--(BUSINESS WIRE)--EyeCare Partners (ECP), the nation’s leading provider of clinically integrated eye care, today announced the grand opening of its Cincinnati Eye Institute (CEI) Retina Clinic at The Landings in Blue Ash, furthering its commitment to providing the highest quality eye care.
Located at 9997 Carver Road, Level 2, in Blue Ash, this new state-of-the-art 36,000-square-foot clinical space is CEI’s 16th office in the greater Cincinnati area.
“As demand for quality eye care continues to rise, we at CEI are ready to meet this challenge through growth and expansion, so our greater Cincinnati area patients continue to enjoy access to world-class eye services right in their own backyard,” said James Osher, M.D., a third-generation Cincinnati ophthalmologist and Ohio Division Medical Director for EyeCare Partners.
“What makes this office so special is its singular focus on medical and surgical treatment of the retina,” added Osher. “The office is unique with state-of-the-art retina equipment, including the most advanced retina imaging platforms available. We will also be able to expand our bustling clinical trial and research services. This allows more patients the opportunity to participate in cutting-edge therapies.”
The new CEI Retina Clinic supports the expansion of CEI’s clinical trial capabilities, allowing patients access to investigational medical and surgical care. Currently, CEI has 28 active retina clinical trials.
“At CEI, we are focused on enhancing vision, advancing eye care and improving lives. The new CEI Retina Clinic advances our mission with world-class specialists working with the latest technology in a patient-friendly space,” said Daniel M. Miller, M.D., Ph.D., Ophthalmology Division President and Executive Medical Officer, EyeCare Partners. “CEI is also pioneering the future of eye care through our robust clinical trial programs in the Cincinnati area, and this space will help advance the future of retina care broadly.”
About Retinal Diseases
Retinal diseases currently impact more than 10 million Americans. These diseases affect the retina, the light-sensitive tissue located in the back of the eye. Common retinal diseases include diabetic retinopathy, macular degeneration, retinal tears and detachments, macular holes and retinitis pigmentosa. Retinal diseases can cause symptoms that impact vision, such as blindness or low vision. The most common causes of retinal damage include genetic and environmental factors, and these can be related to old age, light damage or trauma.
About EyeCare Partners
EyeCare Partners is the nation’s leading provider of clinically integrated eye care. Our national network of over 300 ophthalmologists and 700 optometrists provides a lifetime of care to our patients with a mission to enhance vision, advance eye care and improve lives. Based in St. Louis, Missouri, over 700 ECP-affiliated practice locations provide services that span the eye care continuum in 18 states and 30 markets. For more information, visit www.eyecare-partners.com, and follow us on LinkedIn.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
靶点
-药物
-来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。